Clinical Characterisation Protocol (CCP) for severe emerging infections in the UK
Coronavirus Clinical Characterisation Consortium (ISARIC-4C) / CCP-UK
Site and lead:
- ORC: Dr Dougal Atkinson
- Wythenshawe Hospital: Dr Andrew Bentley
Patient group: all COVID-19 patients
Funder: Wellcome Trust
Sponsor: University of Oxford
More about ISARIC CCP
- ISARIC CCP is a nationally-prioritised COVID-19 study. See the full list Urgent Public Health COVID-19 Studies on the NIHR website.
This primary purpose of this study is the rapid, coordinated clinical investigation of patients with confirmed novel coronavirus infection.
The study has been designed to maximise the likelihood that as much data as possible is collected and shared rapidly in a format that can be easily aggregated, tabulated and analysed across many different settings globally. The study is designed to have some level of flexibility in order to ensure the broadest acceptance.